CYTK: Cytokinetics Incorporated
CYTK exchange rate has changed by 2.53% for today. During the day, the instrument was traded at a low of 78.82 and at a high of 81.55.
Follow Cytokinetics Incorporated dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CYTK News
- Are Medical Stocks Lagging Concentra Group Holdings Parent, Inc. (CON) This Year?
- All You Need to Know About Cytokinetics (CYTK) Rating Upgrade to Buy
- Wall Street Analysts Think Cytokinetics (CYTK) Could Surge 30.54%: Read This Before Placing a Bet
- Apple Shines As It Nears Fresh High, Leads 18 Hot Picks Onto Best Stock Lists
- Will Myqorzo Drive Cytokinetics Higher Despite Competitive Pressure?
- AMD, Micron Spearhead Chip Sector Surge, Lead 23 Hot Prospects To Best Stock Lists
- Entertainment Stocks Madison Square Garden, Sphere Rally To New Highs
- Cytokinetics Gains 18.4% Year to Date: How to Play the Stock?
- Can BMY's Camzyos Strengthen Its Cardiovascular Portfolio?
- Edgewise Bounds Between Double-Digit Losses And Gain — What's Going On?
- A veteran investor is kicking Tesla out of the ‘Magnificent Seven’ — replacing it with this tech giant
- Top Analyst Reports for Costco, Lam Research & KLA
- Cytokinetics, Incorporated (CYTK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
- Why Is Cytokinetics (CYTK) Down 5.5% Since Last Earnings Report?
- How Edgewise Sweetened Its Coffers By $1.55 Billion, And Removed A Key Overhang
- Cytokinetics, Incorporated (CYTK) Shareholder/Analyst Call Prepared Remarks Transcript
- Cytokinetics: Aficamten Has Momentum, But The Stock Is Too Expensive (NASDAQ:CYTK)
- CYTK Q1 Earnings Match Estimates, Revenues Beat on Myqorzo Launch
Frequently Asked Questions
What is CYTK stock price today?
Cytokinetics Incorporated stock is priced at 81.11 today. It trades within 78.82 - 81.55, yesterday's close was 79.11, and trading volume reached 2560. The live price chart of CYTK shows these updates.
Does Cytokinetics Incorporated stock pay dividends?
Cytokinetics Incorporated is currently valued at 81.11. Dividend policy depends on the company, while investors also watch 39.60% and USD. View the chart live to track CYTK movements.
How to buy CYTK stock?
You can buy Cytokinetics Incorporated shares at the current price of 81.11. Orders are usually placed near 81.11 or 81.41, while 2560 and 2.71% show market activity. Follow CYTK updates on the live chart today.
How to invest into CYTK stock?
Investing in Cytokinetics Incorporated involves considering the yearly range 57.83 - 88.31 and current price 81.11. Many compare -4.11% and 30.61% before placing orders at 81.11 or 81.41. Explore the CYTK price chart live with daily changes.
What are Cytokinetics Incorporated stock highest prices?
The highest price of Cytokinetics Incorporated in the past year was 88.31. Within 57.83 - 88.31, the stock fluctuated notably, and comparing with 79.11 helps spot resistance levels. Track Cytokinetics Incorporated performance using the live chart.
What are Cytokinetics Incorporated stock lowest prices?
The lowest price of Cytokinetics Incorporated (CYTK) over the year was 57.83. Comparing it with the current 81.11 and 57.83 - 88.31 shows potential long-term entry points. Watch CYTK moves on the chart live for more details.
When did CYTK stock split?
Cytokinetics Incorporated has gone through stock splits historically. These changes are visible in , 79.11, and 39.60% after corporate actions.
- Previous Close
- 79.11
- Open
- 78.97
- Bid
- 81.11
- Ask
- 81.41
- Low
- 78.82
- High
- 81.55
- Volume
- 2.560 K
- Daily Change
- 2.53%
- Month Change
- -4.11%
- 6 Months Change
- 30.61%
- Year Change
- 39.60%
- Act
- Fcst
- 1.978 M
- Prev
- -1.692 M
- Act
- Fcst
- 0.992 M
- Prev
- 0.430 M
- Act
- Fcst
- Prev
- 4.927%